financetom
Business
financetom
/
Business
/
Aflac Q3 Adjusted Earnings, Revenue Increase; Quarterly Dividend Maintained
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aflac Q3 Adjusted Earnings, Revenue Increase; Quarterly Dividend Maintained
Nov 4, 2025 1:39 PM

04:26 PM EST, 11/04/2025 (MT Newswires) -- Aflac ( AFL ) reported Q3 adjusted earnings late Tuesday of $2.49 per diluted share, up from $2.16 a year earlier.

Analysts polled by FactSet expected $1.77.

Revenue for the quarter ended Sept. 30 was $4.74 billion, up from $2.95 billion a year earlier.

Analysts expected $4.37 billion.

The company maintained its quarterly dividend at $0.58 per share, payable Dec. 1 to holders of record Nov. 19. Aflac ( AFL ) repurchased 9.3 million shares for $1 billion in Q3, leaving 121.6 million shares authorized for future buybacks as of Sept. 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Oct 29, 2025
By Jesús Aguado MADRID (Reuters) -Spain's Santander bank reported a 7.8% year-on-year rise in its third-quarter net profit, saying a strong performance in its U.S. business offset lower lending income and some weakness in Brazil. The net profit of 3.5 billion euros ($4.08 billion) in the July-September quarter reported by the euro zone's biggest bank came above the 3.39 billion...
New Gold Q3 Adjusted Net Income, Revenue Increase
New Gold Q3 Adjusted Net Income, Revenue Increase
Oct 29, 2025
03:49 AM EDT, 10/29/2025 (MT Newswires) -- New Gold ( NGD ) reported Q3 adjusted net income late Tuesday of $0.25 per diluted share, up from $0.08 a year earlier. Analysts polled by FactSet expected $0.18. Revenue for the quarter was $462.5 million, up from $252 million a year earlier. Three analysts surveyed by FactSet expected $419.8 million. Shares of...
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 29, 2025
ZURICH and NESS ZIONA, Israel, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLS or the Company) and Kadimastem Ltd. (TASE: KDST) (Kadimastem ( KMSTF )) today announced that, following the receipt of Nasdaq's approval for the listing of the Company's common shares and the trading of the Company on the Nasdaq Capital Market after completion of the merger between the Company, NLS...
Archrock Q3 Adjusted Earnings, Revenue Rise
Archrock Q3 Adjusted Earnings, Revenue Rise
Oct 29, 2025
03:55 AM EDT, 10/29/2025 (MT Newswires) -- Archrock ( AROC ) reported Q3 adjusted earnings late Tuesday of $0.42 per diluted share, up from $0.28 a year earlier. Three analysts polled by FactSet expected $0.42. Revenue for the quarter ended Sept. 30 was $382.4 million, up from $292.2 million a year earlier. Analysts surveyed by FactSet expected $378.2 million. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved